Bright Uro, Inc. – Trademark Portfolio

Entity Type: 03

Bright Uro, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include GLEAN and IUFLOW. The owner is based in Irvine, CA.

3 Goddard

Irvine, CA 92618

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Bright Uro, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Bright Uro, Inc. have?

Bright Uro, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending.

What trademark classes does Bright Uro, Inc. file in?

Bright Uro, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Bright Uro, Inc.'s most well-known trademarks?

Bright Uro, Inc.'s registered trademark portfolio includes well-known marks such as GLEAN and IUFLOW. These are among 2 currently registered trademarks in the portfolio.

What is Bright Uro, Inc.'s trademark registration success rate?

Bright Uro, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.